Pyridoxamine dihydrochloride clinical trials
A product of Pyridoxamine; its studies count on that page too.
How each study uses pyridoxamine dihydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2001 (1)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 1
NephroGenex, Inc. (2) · BioStratum (2) · Columbia University (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Pyridoxamine
Studies
Open first, then newest update. How each study uses pyridoxamine dihydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With PyridoxamineCompletedNot applicableColumbia UniversityNCT03778580Written as Pyridoxamine Dihydrochloride
- Pyridorin in Diabetic NephropathyTerminatedPhase 3NephroGenex, Inc.NCT02156843Written as Pyridorin
- Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 DiabetesCompletedPhase 2NephroGenex, Inc.NCT00734253Written as Pyridoxamine Dihydrochloride
- Effect of Pyridorin in Patients With Diabetic NephropathyCompletedPhase 2BioStratumNCT00320060Written as Pyridorin (pyridoxamine dihydrochloride)
- Effect of Pyridorin in Patients With Diabetic NephropathyCompletedPhase 2BioStratumNCT00320021Written as Pyridorin (pyridoxamine dihydrochloride)
Codes
What other systems call pyridoxamine dihydrochloride · ClinicalTrials.gg INT005999
- MeSH (NLM) C570561pyridoxamine dihydrochlorideOne source NLM
- UNII (FDA) YQ8NCR7V0OPYRIDOXAMINE DIHYDROCHLORIDEConfirmed NLM, Wikidata
- Wikidata Q27225159pyridoxamine dihydrochlorideConfirmed NLM, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C570561 | pyridoxamine dihydrochloride | One source NLM |
| UNII (FDA) | YQ8NCR7V0O | PYRIDOXAMINE DIHYDROCHLORIDE | Confirmed NLM, Wikidata |
| Wikidata | Q27225159 | pyridoxamine dihydrochloride | Confirmed NLM, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.